13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Clinical Neurology
Advancements in clinical neurology are reshaping the landscape of neurological healthcare. The field explores a spectrum of disorders, from common headaches to intricate conditions like multiple sclerosis and epilepsy. Pioneering research drives the development of minimally invasive procedures and novel pharmaceutical agents, revolutionizing treatment paradigms. Clinical Neurology highlights the importance of early diagnosis through biomarkers and electrophysiological tools, which facilitate timely intervention. Additionally, the integration of neuroinformatics and personalized medicine offers insights into patient-specific therapies, enhancing the effectiveness of treatments. With a focus on holistic care, Clinical Neurology strives to improve the quality of life for individuals while addressing emerging challenges in neurodiagnostics and therapeutic methodologies.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States